Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clearpoint Neuro Inc (CLPT)

Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 361,256
  • Shares Outstanding, K 28,423
  • Annual Sales, $ 31,390 K
  • Annual Income, $ -18,910 K
  • EBIT $ -23 M
  • EBITDA $ -21 M
  • 60-Month Beta 1.01
  • Price/Sales 11.74
  • Price/Cash Flow N/A
  • Price/Book 23.22

Options Overview Details

View History
  • Implied Volatility 83.84% (-0.46%)
  • Historical Volatility 87.95%
  • IV Percentile 68%
  • IV Rank 46.71%
  • IV High 126.04% on 04/10/25
  • IV Low 46.85% on 05/22/25
  • Expected Move (DTE 3) 0.85 (6.87%)
  • Put/Call Vol Ratio 0.31
  • Today's Volume 353
  • Volume Avg (30-Day) 508
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 17,247
  • Open Int (30-Day) 18,603
  • Expected Range 11.53 to 13.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.25 +1.06%
on 12/15/25
15.57 -20.50%
on 11/17/25
-3.05 (-19.77%)
since 11/14/25
3-Month
10.33 +19.80%
on 09/16/25
30.10 -58.87%
on 10/09/25
+1.91 (+18.24%)
since 09/15/25
52-Week
9.76 +26.84%
on 04/07/25
30.10 -58.87%
on 10/09/25
-2.94 (-19.22%)
since 12/13/24

Most Recent Stories

More News
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), BioLife Solutions (BLFS) and Viking Therapeutics (VKTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ClearPoint Neuro (CLPT – Research Report), BioLife Solutions (BLFS – Research Report) and Viking Therapeutics...

VKTX : 36.15 (-2.51%)
CLPT : 12.38 (-2.60%)
BLFS : 24.65 (+1.07%)
Small Cap Gene Therapy Stock More Than Triples on Positive Trial Results

Shares of uniQure (NASDAQ: QURE) staged one of the most dramatic rallies of the year on Wednesday, more than tripling after the biotech unveiled pivotal trial data showing its experimental Huntington’s...

QURE : 20.43 (+4.72%)
CLPT : 12.38 (-2.60%)
HTGC : 18.67 (-0.85%)
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain...

CLPT : 12.38 (-2.60%)
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

SOLANA BEACH, CA / ACCESS Newswire / April 25, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain...

CLPT : 12.38 (-2.60%)
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

The platform will be showcased at the American Academy of Neurological Surgeons Annual Meeting in Boston on April 25-28, 2025.

CLPT : 12.38 (-2.60%)
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Achieved Record Revenue for 2024 and Growth of 31%;

CLPT : 12.38 (-2.60%)
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

SOLANA BEACH, CA / ACCESS Newswire / February 14, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the...

CLPT : 12.38 (-2.60%)
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

SOLANA BEACH, CA / ACCESS Newswire / February 12, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the...

CLPT : 12.38 (-2.60%)
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation...

CLPT : 12.38 (-2.60%)
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

CLPT : 12.38 (-2.60%)

Business Summary

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

See More

Key Turning Points

3rd Resistance Point 13.38
2nd Resistance Point 13.13
1st Resistance Point 12.75
Last Price 12.38
1st Support Level 12.13
2nd Support Level 11.88
3rd Support Level 11.50

See More

52-Week High 30.10
Fibonacci 61.8% 22.33
Fibonacci 50% 19.93
Fibonacci 38.2% 17.53
Last Price 12.38
52-Week Low 9.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar